AP Biosciences Inc (TPEX:6945)
Taiwan
· Delayed Price · Currency is TWD 169.00
+4.00 (2.42%)
Mar 10, 2026, 9:59 AM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 14.12 billion as of March 9, 2026. Its market cap has increased by 209.96% in one year.
Market Cap
14.12B
Enterprise Value
12.91B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
169.00
Market Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 14.12B, an increase of 177.09%. That is a compound annual growth rate of 46.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 14.46B | -5.60% |
| Dec 31, 2025 | 15.32B | 262.77% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TaiMed Biologics | 14.62B |
| TCM Biotech International | 14.02B |
| Ever Supreme Bio Technology | 12.66B |
| Medigen Vaccine Biologics | 12.10B |
| Tanvex BioPharma | 11.86B |
| EirGenix | 18.10B |
| Sunmax Biotechnology | 21.21B |
| Gongwin Biopharm Holdings | 9.81B |